Financial Performance - The company's operating revenue for Q1 2024 was CNY 331,313,681.76, representing a decrease of 42.91% compared to the same period last year[4] - The net profit attributable to shareholders was CNY 67,302,017.75, down 61.83% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 66,186,753.50, a decrease of 61.72% compared to the previous year[4] - Basic and diluted earnings per share were both CNY 0.81, down 61.74% year-on-year[5] - Total revenue for Q1 2024 was CNY 331,313,681.76, a decrease of 42.9% compared to CNY 580,338,886.76 in Q1 2023[21] - Net profit for Q1 2024 was CNY 66,365,669.63, a decline of 62.2% compared to CNY 175,096,001.77 in Q1 2023[22] - The total comprehensive income for the first quarter of 2024 was CNY 68,676,034.92, compared to CNY 175,078,386.74 in the same period of 2023, indicating a significant decrease[23] - Basic and diluted earnings per share for Q1 2024 were both CNY 0.81, down from CNY 2.12 in Q1 2023[23] Cash Flow and Assets - The net cash flow from operating activities was CNY 78,311,759.24, reflecting a slowdown in sales growth and reduced procurement expenditures[5] - The net cash flow from operating activities for Q1 2024 was CNY 78,311,759.24, a recovery from a negative cash flow of CNY -92,449,196.32 in Q1 2023[25] - Cash received from sales of goods and services amounted to CNY 358,858,355.00 in Q1 2024, down from CNY 586,464,198.85 in Q1 2023[25] - The net cash outflow from investing activities was CNY -169,082,449.96 in Q1 2024, compared to a net inflow of CNY 94,615,746.91 in Q1 2023[26] - The net cash flow from financing activities was CNY 75,986,908.43 in Q1 2024, recovering from a net outflow of CNY -23,304,212.02 in Q1 2023[26] - The company's cash and cash equivalents were reported at RMB 4.76 billion, slightly down from RMB 4.84 billion in the previous period, indicating a decrease of approximately 1.0%[18] - The total cash and cash equivalents at the end of Q1 2024 were CNY 4,653,044,333.61, slightly down from CNY 5,236,787,714.48 at the end of Q1 2023[26] Research and Development - R&D investment totaled CNY 51,520,387.42, an increase of 39.94% compared to the previous year, accounting for 15.55% of operating revenue, up 9.21 percentage points[5] - Research and development expenses increased to CNY 51,520,387.42 in Q1 2024, up 39.8% from CNY 36,816,742.48 in Q1 2023[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,382,750,097.37, an increase of 2.15% from the end of the previous year[5] - Total assets as of Q1 2024 amounted to CNY 7,382,750,097.37, an increase from CNY 7,227,697,315.17 in Q1 2023[20] - Total liabilities for Q1 2024 were CNY 946,258,178.49, compared to CNY 848,530,433.04 in Q1 2023, reflecting an increase of 11.5%[20] - The total liabilities of the company as of March 31, 2024, are not explicitly stated but are essential for assessing the financial health in future reports[16] Operational Focus - The company attributed the decline in revenue and profit to a slowdown in sales growth due to the overall industry environment, while increasing investments in R&D and management for long-term development[8] - The company has not reported any new significant products or technologies in this quarter, focusing instead on optimizing existing operations[16] - There are no new strategies or market expansions mentioned in the current report, indicating a stable operational focus[16] - The company has not disclosed any mergers or acquisitions during this reporting period, suggesting a cautious approach to growth[16] - The report does not indicate any changes in the major shareholders or their stakes, maintaining stability in ownership[16] Shareholder Information - The company has a total of 7,187 common shareholders at the end of the reporting period[10]
禾迈股份(688032) - 2024 Q1 - 季度财报